Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Inogen, Inc (INGN) vs RxSight, Inc. (RXST)

Inogen, Inc and RxSight, Inc. are both Medical Devices companies. RxSight, Inc. is the larger, with a market value of $196.7M against $138.8M — 1.4× the size. Inogen, Inc grew revenue faster over the last twelve months: 3.15% against −13.3%. Inogen, Inc has the higher net margin (−6.94% vs −36.8%) and the higher return on invested capital (−28.4% vs −63.2%). Across the 17 metrics below, Inogen, Inc leads on 11 and RxSight, Inc. on 6.

Valuation

Metric INGN RXST Medical Devices median
P/E n/m n/m 22.18
P/S 0.41 1.52 2.70
P/B 0.83 0.73 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 0.24 11.78
EV/Sales 0.17 (0.11) 2.38
Earnings yield (16.79%) (24.25%) (8.22%)
Free cash flow yield (5.42%) (14.05%) (7.80%)

Profitability

Metric INGN RXST Medical Devices median
Gross margin 44.51% 77.50% 56.01%
Operating margin (8.71%) (43.20%) (15.03%)
Net margin (6.94%) (36.80%) (20.40%)
Free cash flow margin (2.22%) (21.29%) (7.24%)
Return on equity (13.14%) (17.35%) (15.32%)
Return on assets (8.23%) (14.19%) (19.72%)
Return on invested capital (28.35%) (63.16%) (10.33%)

Growth

Metric INGN RXST Medical Devices median
Revenue growth (TTM) 3.15% (13.25%) 8.80%
EPS growth (last fiscal year) 43.42% (33.80%) —
Revenue growth, 5-year CAGR 2.48% 55.74% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INGN RXST Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 2.74 4.07 2.50
Net debt to EBITDA 12.66 4.27 0.49

Dividend

Metric INGN RXST Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric INGN RXST Medical Devices median
Market cap 138.80m 196.74m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack